lp-a.org

Epidemiology

Lp(a) and homocysteine together raise coronary risk nearly 5-fold in women, but not men, a study of 750 men and 403 women (Arterioscler Thromb Vasc Biol 2000)

Original title: Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women

Arterioscler Thromb Vasc Biol · · 7

Foody JM, Milberg JA, Robinson K, Pearce GL, Jacobsen DW, Sprecher DL

This cross-sectional study examined 750 men and 403 women referred to a preventive cardiology clinic to test whether homocysteine and Lp(a) interact to raise coronary artery disease (CAD) risk. In women, neither isolated high homocysteine (odds ratio 1.06, P=0.89) nor isolated high Lp(a) (odds ratio 1.15, P=0.60) was associated with CAD, but both together carried a strong association (odds ratio 4.83, P=0.003), with evidence of a true interactive effect beyond additive or multiplicative expectations (P=0.03). In men, both elevated homocysteine (odds ratio 1.93, P=0.05) and elevated Lp(a) (odds ratio 1.87, P=0.01) were independent CAD risk factors, but having both together conferred no additional risk (odds ratio 2.00, P=0.09), despite odds ratios as high as 12.4 within specific age intervals. The findings show homocysteine and Lp(a) interact synergistically to raise CAD risk in women but act independently in men, offering insight into their combined role in atherosclerosis.

Read the paper (DOI)PubMed

Original abstract

A biochemical link between homocysteine (tHcy) and lipoprotein(a) [Lp(a)] related to fibrin binding has been proposed. This hypothesis has not been specifically examined in human subjects. We sought to determine in a clinical setting whether these risk factors would interact to increase coronary artery disease (CAD) risk. We performed a cross-sectional analysis of 750 men and 403 women referred to a preventive cardiology clinic at the Cleveland Clinic Foundation, in whom baseline tHcy and Lp(a) data were available. Logistic regression after adjusting for standard cardiovascular risk factors was used to estimate the relative risk of CAD in patients with an Lp(a) >/=30 mg/dL and a tHcy >/=17 micromol/L. Neither isolated high tHcy (odds ratio [OR]=1.06, P=0.89) nor isolated high Lp(a) (OR=1.15, P=0.60) appeared to be associated with CAD in women. However, strong evidence of an association was seen when both risk factors were present (OR=4.83, P=0.003). Moreover, this increased risk showed evidence of an interactive effect beyond that attributable to either additive or multiplicative effects of tHcy and Lp(a) (P=0.03). In contrast, both elevated tHcy (OR=1.93, P=0. 05) and elevated Lp(a) (OR=1.87, P=0.01) showed evidence of being independent risk factors for CAD in men. The presence of both risk factors in men did not appear to confer additional risk (OR=2.00, P=0.09), even though ORs as high as 12.4 were observed within specific age intervals. Consistent with prior studies, tHcy and Lp(a) are risk factors, either independently or in concert, for CAD in this clinical population. More significantly, we found evidence that when both risk factors were present in women, the associated risk was greater than what would be expected if the 2 risks were simply acting independently. The absence of such an interactive effect in men may be due to the confounding effects of age manifested as "survivor bias." These clinical findings provide insights into the potential roles of both tHcy and Lp(a) in the pathogenesis of atherosclerosis.

epidemiologythrombosiswomen

Summary written by lp-a.org from the published abstract; figures as published. Page updated 18 August 2026. Methods.